Metformin can alleviate the symptom of patient with diabetic nephropathy through reducing the serum level of Hcy and IL-33

Interleukin-33 (IL-33) and homocysteine (Hcy) were found to be up-regulated in patients with diabetic nephropathy (DN), and the present study aimed to investigate whether metformin (MT) can influence the serum levels of IL-33 and Hcy in patients with DN.

Bibliographic Details

Published in:	Open Medicine
Main Authors:	Zhang Ling, Niu Jiansheng, Zhang Xiumei, He Wanxia
Format:	Article
Language:	English
Published:	De Gruyter 2019-08-01
Subjects:	metformin il-33 hcy diabetic nephropathy
Online Access:	https://doi.org/10.1515/med-2019-0071